SCHEMBL6569824

SCHEMBL6569824

C1=CCC2=Cc3cc4ccccc4cc3C2=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2591449 0.88 GAPDH (0.31)
SCHEMBL30502984 0.79 PTGS2 (0.34)
SCHEMBL710125 0.79 PTGS2 (0.34)
SCHEMBL27800017 0.77 PTGS2 (0.33)
SCHEMBL28242714 0.73 PARP11 (0.35)
SCHEMBL4847072 0.71 ALDH1A1 (0.42)
SCHEMBL25567695 0.71
SCHEMBL3707104 0.70 CDC25B (0.41)
SCHEMBL5310650 0.69 CDC25B (0.40)
SCHEMBL7771419 0.67 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478613-A2 SUBSTITUTED 10-ARYL-11H-BENZO[B]FLUORENES AND 7-ARYL-5,6-DIHYDRO-BENZ[A]ANTHRACENES FOR SELECTIVE EFFECTS ON ESTROGEN RECEPTORS Akzo Nobel N.V. (NL) 2004-11-24 EP disclosed
WO-2003070675-A2 SUBSTITUTED 10-ARYL-11H-BENZO[B]FLUORENES AND 7-ARYL-5,6-DIHYDRO-BENZO[A]ANTHRACENES FOR SELECTIVE EFFECTS ON ESTROGEN RECEPTORS AKZO NOBEL N.V. (NL) 2003-08-28 WO disclosed
EP-1313700-A1 10-ARYL-11H-BENZO[B]FLUORENE DERIVATIVES AND ANALOGS AS ESTROGENIC COMPOUNDS Akzo Nobel N.V. (NL) 2003-05-28 EP disclosed
EP-1272471-A1 NON-STEROIDAL, TETRACYCLIC COMPOUNDS FOR ESTROGEN-RELATED TREATMENTS Akzo Nobel N.V. (NL) 2003-01-08 EP disclosed
WO-2002016316-A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE AKZO NOBEL N.V. (NL) 2002-02-28 WO disclosed
WO-2001072713-A1 NON-STEROIDAL, TETRACYCLIC COMPOUNDS FOR ESTROGEN-RELATED TREATMENTS AKZO NOBEL N.V. (NL) 2001-10-04 WO disclosed